Then, we decided to additionally determine the expression of the N-MYC oncogene and the nearest circle of regulatory genes (SPT16, AURKA, AURKB) whose expression is often elevated in neuroblastoma and remains unstudied in adult patients with AML, including FLT3-ITD mutation carriers. This evidence concerns the gene AURKB and acute myeloid leukemia.